My background as a serial entrepreneur and software architect spans over 20 years of running lean technology organizations and numerous innovative initiatives.
As co-founder and CEO of OxyDial, I lead a fast-growing engineering company that has developed a next-generation blood testing instrument for measuring the Oxygen-hemoglobin Dissociation Curve and MetHemoglobin. We aim to streamline pharma R&D, Clinical Care, and improve outcomes for patients suffering blood disorders worldwide.
